4. How did the smallpox vaccination program come about?

Rose, Dale A.

doi:10.7312/lako14606-004

Cited by 11 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study on the Smallpox Vaccination Programme in the USA, Dale Rose found that, under the new security rationale, there was a willingness to accept a much higher risk of side-effects of the vaccine than had been acceptable from a public health rationale. 70 A similar logic seems to have been at play when decisions were made to expand the use of pharmaceutical interventions in the international Ebola response. not only do securitisation processes encourage technological solutions, then, but the political urgency associated with them facilitates the implantation of extraordinary measures, notably the mobilisation of public funds for pharmaceutical development, the use of drugs that have never been tested in humans and the acceleration of pharmaceutical development.…”

Section: Exceptions: Extraordinary Measures For Pharmaceutical Innovationmentioning

confidence: 94%

The race for Ebola drugs: pharmaceuticals, security and global health governance

Roemer-Mahler¹

The International Politics of Ebola

View full text Add to dashboard Cite

The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines. This article identifies three mechanisms that interlink these trends. First, securitisation encourages technological policy responses. Second, it creates an exceptional political space in which pharmaceutical development can be freed from constraints. Third, it creates an institutional architecture that facilitates pharmaceutical policy responses. The ways in which the securitisation of health reinforces pharmaceutical policy strategies must, the article concludes, be included in ongoing efforts to evaluate them normatively and politically.

show abstract

Section: Exceptions: Extraordinary Measures For Pharmaceutical Innovationmentioning

confidence: 94%

The race for Ebola drugs: pharmaceuticals, security and global health governance

Roemer-Mahler¹

The International Politics of Ebola

View full text Add to dashboard Cite

show abstract

The Rise of Global Health Emergency Governance

Rabi

2024

Minerva

View full text Add to dashboard Cite

In this paper I shed new light on contemporary developments in global health governance, policymaking, and knowledge production. Specifically, by investigating the historical roots and emergence of global health emergency governance. Drawing on the Foucauldian notion of “problematisation” and on Science and Technology Studies of disaster, I trace, examine, and elucidate three main axes through which, I argue, health emergencies became a problem of global governance. I show, first, the formation of emergency management as a distinct professional field. Second, the migration of emergency management into global health governance and its proliferation within it. And third, the move from global health emergency management to the global governance of health emergencies. Overall, I suggest the rise of global health emergency governance provides crucial context for understanding social, political, and epistemic tensions and controversies in health emergencies such as COVID-19. Through the analysis, I identify a particular rationale that is rooted in emergency management and had become embedded in global health emergency governance. A rationale that involves “temporal compression” and “structural plasticity.” I discuss possible implications of this rationale for global health governance, policy, and knowledge.

show abstract

Public prophylaxis: Pandemic influenza, pharmaceutical prevention and participatory governance

Caduff

2010

BioSocieties

View full text Add to dashboard Cite

In this article, I explore recent discussions among American public health professionals over how to protect the health of the nation in a state of emergency. My focus is specifically on questions of preventative strategy and population management, examining intensive debates around the prioritization of protective vaccine for pandemic influenza. Drawing on ethnographic research, I show how the mode of circulation, distribution and allocation of pandemic vaccine was gradually refashioned in the United States over the past 2 years. When government officials launched public engagement meetings reformulating in ethical terms the crucial question of how to dispense a scarce pharmaceutical resource in a public health emergency, a distinctive set of priorities emerged. My aim, in this article, is to examine this ethical refashioning and to interrogate the curious logics of public-ness that are increasingly embedded in a growing number of approaches of public health professionals. How are populations gathered into the fold of pharmaceutical prevention today?

show abstract

4. How did the smallpox vaccination program come about?

Cited by 11 publications

References 18 publications

The race for Ebola drugs: pharmaceuticals, security and global health governance

The race for Ebola drugs: pharmaceuticals, security and global health governance

The Rise of Global Health Emergency Governance

Public prophylaxis: Pandemic influenza, pharmaceutical prevention and participatory governance

Contact Info

Product

Resources

About